DOJ’s April 23 order immediately moves FDA approved marijuana products and marijuana products tied to a qualifying state medical marijuana license into Schedule III, and the wider federal rescheduling question is still headed into a new DEA hearing that starts June 29, 2026.
The April 23 DOJ cannabis order
The federal change announced today is narrow but important. DOJ said the order takes effect right away for two groups only. One is FDA approved products containing marijuana. The other is marijuana products regulated through a qualifying state medical marijuana license. DOJ also said DEA is opening a new administrative hearing path for the broader rescheduling question, with that hearing set to begin June 29, 2026.
For Illinois readers, that means the biggest federal headline today sits on the medical side first. The broader rewrite for marijuana as a whole is still moving through rulemaking. That distinction is the part shoppers need to keep straight when headlines start using broad phrases about cannabis and Schedule III.
Products covered right now
The immediate order reaches products by license status, not just by product format. A jar of flower, a package of edibles, a vape, a tincture or a topical does not fall inside today’s federal move just because of what it is. The key question is the lane the product moves through. If it is sold under a qualifying state medical marijuana license, it is in the group DOJ covered right away.
That is the plain-English way to read this order at store level. A medical sale tied to Illinois’ licensed patient system fits inside the federal move announced today. A standard adult-use sale does not get pulled into the immediate change simply because the item looks similar or comes from the same store. DOJ described a medical-license lane, not a full adult-use rewrite.
Broader rescheduling is still pending
DOJ also said the broader federal rescheduling question is still in process. The department said DEA is withdrawing the prior hearing notice and starting a new hearing track. The new hearing begins June 29, 2026, and DOJ described it as the path for considering the wider move from Schedule I to Schedule III.
That means today’s order should not be read as a full federal reset for every cannabis product in every state channel. The medical categories DOJ named got the immediate move. The wider status of marijuana under federal law is still being worked through in the hearing and rulemaking process.
Illinois shopper rules still stay the same
If you are shopping in Illinois, the state’s basic adult-use rules stay the same today. Illinois says adults 21 and older may legally possess up to 30 grams of cannabis flower, 500 milligrams of THC in infused products and 5 grams of concentrate. Nonresidents may possess half those amounts. Those limits come from Illinois law, and nothing in DOJ’s release changes them today.
That means a regular adult-use shopper still checks out under the same Illinois cap system that was in place before the federal order. If you are buying pre-rolls, extracts or other adult-use items, your age check, possession cap and state use rules still come from Illinois law at the register.
The Illinois medical patient lane still has its own rules
Illinois medical patients still move through their own allotment system. The state’s medical explainer says the typical patient purchase limit is 2.5 ounces of flower over 14 days. It also gives equivalent amounts for other product types, including 21,300 milligrams in edibles or beverages and 21.3 grams of THC in vapes or concentrates.
Illinois also gives a practical example that makes the system easier to picture. In the state explainer, a 1 gram pre-roll plus a 100 milligram edible counts as 1.33 grams against the patient purchase limit. That example is useful because it shows how the medical side tracks mixed product purchases in one rolling 14-day allotment, not as separate buckets for each category.
Tax treatment is also different. Illinois says medical cannabis is taxed at the qualifying food and drug sales tax rate in the local jurisdiction. Adult-use cannabis is taxed under the general merchandise sales tax rate and can also carry cannabis purchaser excise taxes and local cannabis retailer taxes. So if a patient and an adult-use shopper buy similar products, the tax line on the receipt can still look different even after today’s federal order.
Use and travel limits still apply
Illinois still bars public consumption. The state says cannabis cannot be smoked, vaped, eaten or otherwise used in any public place. Illinois also says use is barred on federal property, including military bases, federal parks and other federal buildings. That part stays important because today’s DOJ order did not erase federal property rules.
Travel rules also stay tight. TSA says marijuana remains illegal under federal law except for limited hemp-related exceptions, and TSA officers must report suspected violations to law enforcement. So if an Illinois shopper buys legally in state, that does not make it safe to carry cannabis across state lines or onto federal property. For practical purposes near the Illinois border, a legal Illinois purchase still should not travel into Indiana, Wisconsin or any other state.
What shoppers may notice over the next few months
At first, you are more likely to notice legal and policy talk than a dramatic checkout change. DOJ framed today’s move around FDA approved marijuana products, state-regulated medical marijuana programs and research. Illinois still controls who can buy under adult-use rules, how much can be possessed in state and where use is barred in public.
At store level, that means ID checks, possession limits, public-use rules and the medical allotment system are the main pieces most shoppers should expect to keep seeing right away. What could draw more attention over the next few months is the federal hearing calendar, legal analysis around covered medical products and any later changes that come out of the broader DEA process. June 29 is the next federal date to watch.
Conclusion
We keep our current store information on the main site so you can check adult-use options, medical details and common store questions in one place.
Visit us for current store information.
Disclaimer: This content is provided for general informational purposes only and should not be interpreted as medical or legal advice. For guidance related to your individual circumstances, consult a qualified healthcare or legal professional and comply with all applicable local and state laws.